Valera Pharmaceuticals, Inc. (NASDAQ: VLRX) announced that the Company completed its acquisition of the New Drug Application and other assets ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE